These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 18698248

  • 1. Impact of cyclosporine A on magnesium homeostasis: clinical observation in lung transplant recipients and experimental study in mice.
    Sabbagh F, El Tawil Z, Lecerf F, Hulin A, Maurois P, Dartevelle P, Bac P, German-Fattal M.
    Transplantation; 2008 Aug 15; 86(3):436-44. PubMed ID: 18698248
    [Abstract] [Full Text] [Related]

  • 2. Magnesium-deficiency does not alter calcineurin inhibitors activity in mice.
    Hulin A, Lamrani L, Sabbagh F, Tallet A, Lecerf F, Bac P, German-Fattal M.
    Transpl Immunol; 2012 Jan 15; 26(1):55-61. PubMed ID: 21964379
    [Abstract] [Full Text] [Related]

  • 3. Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity.
    Holzmacher R, Kendziorski C, Michael Hofman R, Jaffery J, Becker B, Djamali A.
    Nephrol Dial Transplant; 2005 Jul 15; 20(7):1456-62. PubMed ID: 15840674
    [Abstract] [Full Text] [Related]

  • 4. Magnesium supplementation prevents chronic cyclosporine nephrotoxicity via adjusting nitric oxide synthase activity.
    Yuan J, Zhou J, Chen BC, Zhang X, Zhou HM, Du DF, Chang S, Chen ZK.
    Transplant Proc; 2005 May 15; 37(4):1892-5. PubMed ID: 15919495
    [Abstract] [Full Text] [Related]

  • 5. [Non-immunologic factor: immunosuppressive drug-induced nephrotoxicity].
    Nakatani T, Asai T.
    Hinyokika Kiyo; 2002 Nov 15; 48(11):699-705. PubMed ID: 12512145
    [Abstract] [Full Text] [Related]

  • 6. Relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients.
    Ahmadi F, Naseri R, Lessan-Pezeshki M.
    Saudi J Kidney Dis Transpl; 2009 Sep 15; 20(5):766-9. PubMed ID: 19736470
    [Abstract] [Full Text] [Related]

  • 7. Effect of hypomagnesemia on allogeneic activation in mice.
    Sabbagh F, Lecerf F, Hulin A, Bac P, German-Fattal M.
    Transpl Immunol; 2008 Nov 15; 20(1-2):83-7. PubMed ID: 18707001
    [Abstract] [Full Text] [Related]

  • 8. Tacrolimus-associated hypomagnesemia in renal transplant recipients.
    Navaneethan SD, Sankarasubbaiyan S, Gross MD, Jeevanantham V, Monk RD.
    Transplant Proc; 2006 Jun 15; 38(5):1320-2. PubMed ID: 16797291
    [Abstract] [Full Text] [Related]

  • 9. Hypomagnesemia in renal transplant patients: improvement over time and association with hypertension and cyclosporine levels.
    Ramos EL, Barri YM, Kubilis P, Peterson JC, Pfaff WW, Howard RJ, Parris CJ, Patton PR, Karlix JL.
    Clin Transplant; 1995 Jun 15; 9(3 Pt 1):185-9. PubMed ID: 7549058
    [Abstract] [Full Text] [Related]

  • 10. Renal outcome after ciclosporin-induced nephrotoxicity.
    Tostivint I, du Montcel ST, Jaudon MC, Mallet A, Le Hoang P, Bodaghi B, Deray G, Bagnis CI.
    Nephrol Dial Transplant; 2007 Mar 15; 22(3):880-5. PubMed ID: 17127700
    [Abstract] [Full Text] [Related]

  • 11. Ionised and total serum magnesium in renal transplant patients.
    Mazzaferro S, Barberi S, Scarda A, Pasquali M, Rubino F, D'Erasmo E.
    J Nephrol; 2002 Mar 15; 15(3):275-80. PubMed ID: 12113599
    [Abstract] [Full Text] [Related]

  • 12. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression.
    Heering PJ, Kurschat C, Vo DT, Klein-Vehne N, Fehsel K, Ivens K.
    Clin Transplant; 2004 Apr 15; 18(2):186-92. PubMed ID: 15016134
    [Abstract] [Full Text] [Related]

  • 13. Long-term calcineurin inhibition and magnesium balance after renal transplantation.
    Mazzola BL, Vannini SD, Truttmann AC, von Vigier RO, Wermuth B, Ferrari P, Bianchetti MG.
    Transpl Int; 2003 Feb 15; 16(2):76-81. PubMed ID: 12595968
    [Abstract] [Full Text] [Related]

  • 14. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
    Jankauskiene A, Druskis V, Laurinavicius A.
    Clin Nephrol; 2001 Dec 15; 56(6):S27-9. PubMed ID: 11770808
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cyclosporine-induced renal dysfunction in experimental animals and humans.
    Remuzzi G, Perico N.
    Kidney Int Suppl; 1995 Dec 15; 52():S70-4. PubMed ID: 8587288
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cyclosporine induced nephrotoxicity in renal transplant recipients: clinical significance of fractional excretion of sodium, potassium and magnesium.
    Naqvi HN, Zafar MN, Hussain A, Naqvi SA, Rizvi AH.
    J Pak Med Assoc; 2005 Apr 15; 55(4):161-5. PubMed ID: 15918629
    [Abstract] [Full Text] [Related]

  • 19. Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease.
    Sternthal MB, Murphy SJ, George J, Kornbluth A, Lichtiger S, Present DH.
    Am J Gastroenterol; 2008 Apr 15; 103(4):937-43. PubMed ID: 18177449
    [Abstract] [Full Text] [Related]

  • 20. Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy.
    Carstens J.
    Scand J Urol Nephrol; 2008 Apr 15; 42(3):286-92. PubMed ID: 18432535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.